Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™)

BACKGROUND: Additional antibiotic options are needed to treat bone and joint infections caused by penicillin-resistant Gram-positive pathogens. OBJECTIVE: This subanalysis of the Telavancin Observational Use Registry (TOUR™) aimed to record real-world telavancin usage patterns in patients with bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Sims, Charles R., Bressler, Adam M., Graham, Donald R., Lacy, Melinda K., Lombardi, David A., Castaneda-Ruiz, Bibiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153092/
https://www.ncbi.nlm.nih.gov/pubmed/34041706
http://dx.doi.org/10.1007/s40801-021-00255-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153092/
https://www.ncbi.nlm.nih.gov/pubmed/34041706
http://dx.doi.org/10.1007/s40801-021-00255-6

Ejemplares similares